ADAR1 Capital Management »

Organon & Co shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Organon & Co (OGN) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Organon & Co

Tip: Access up to 7 years of quarterly data

All positions including Organon & Co held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Organon & Co by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $59k 3.1k 19.13
2024-06-30 $52k 2.5k 20.70
2024-03-31 $113k 6.0k 18.80

More positions owned by ADAR1 Capital Management

Cytokinetics Com New (CYTK)
Protagonist Therapeutics (PTGX)
Bridgebio Pharma (BBIO)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Royalty Pharma Shs Class A (RPRX)
Keros Therapeutics (KROS)
Ascendis Pharma A/s Sponsored Adr (ASND)
Zura Bio Class A Ord Shs (ZURA)
Zai Lab Adr (ZLAB)
Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA)
Aa Mission Acquisition Corp Ord Shs Cl A (AAM)
Mineralys Therapeutics (MLYS)
Syndax Pharmaceuticals (SNDX)

View all positions for ADAR1 Capital Management

Top funds holding Organon & Co

BlackRock
Vanguard Group
Pacer Advisors
Massachusetts Financial Services
State Street Corporation
LSV Asset Management
Nordea Investment Management Ab
Sound Shore Management
DePrince Race & Zollo
Geode Capital Management
Bank of New York Mellon
Citadel Advisors
Charles Schwab Investment Management
Dimensional Fund Advisors
Russell Investments

View all funds holding Organon & Co